Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Advertisement
News & Opinion
Covering the life sciences inside and out
Most Recent
Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.
A roundup of recent research announced last weekend at the annual conference of the American Association for the Advancement of Science (AAAS).
Designing the simplest possible living organism artificially may lend clues as to what life is.
Researchers develop a tiny device that motors around the stomach, fueled by its acidic environment.
Starvation paired with cancer drugs slowed or stopped unchecked cell growth in yeast and mouse models of cancer, outpacing or matching the isolated effects of chemo.
A single mutant cell breaks free of its neighbors in the early stages of cancer development.
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Biomedical research can learn from citizen science, which is grounded in strong relationships with study participants.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- genetics & genomics
- neuroscience
- opinion
- techniques
Sub Categories
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
